This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Sign In   |   Register
News: Publications

Journal highlights July: Biomarkers are important tools

Tuesday 27 August 2019   (0 Comments)
Share |

In our regular feature, Editor-in-Chief Arnold von Eckardstein highlights interesting articles from recent issues of Atherosclerosis journal. The highlights are an easy way for you to get an overview of the issue content every month.

Biomarkers are important tools of risk assessment, diagnosis of disease, stratification for different therapeutic options, and monitoring of safety and efficacy of treatment. This issue of Atherosclerosis contains several articles on studies aimed at validation of established biomarkers, as part of novel models or towards novel disease endpoints, or at validation of novel biomarker candidates.

To Journal Highlights July>>

To the July issue of Atherosclerosis>>


Atherosclerosis is now present on Facebook (Atherosclerosis - Journal of the European Atherosclerosis Society) and Twitter (@ATHjournal). Join our social media community and follow us!

Membership Software Powered by YourMembership  ::  Legal